ATLANTA--(BUSINESS WIRE)--July 17, 2006--MIV Therapeutics (OTCBB:MIVT - News; FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has announced the availability of a transcript of the conference call held on Tuesday, July 11, in which CEO Alan Lindsay and Company President Dr. Mark Landy discussed key elements of MIVT’s bio-compatible stent technology, as well as recent scientific research and industry trends.
